Although evidence suggests that Aβ deposition and tau pathology can precede neuronal and synaptic loss [47,48,49], especially considering observations from longitudinal imaging of dystrophic neurites and plaques in rodent AD models [50,51,52], the precise timing of the start of neuronal and synaptic loss in AD patients remains to be accurately determined. The gene discussed is MAPT; the disease is Alzheimer disease.